Skip to main content
Clinical Trials/JPRN-jRCT1080223125
JPRN-jRCT1080223125
Other
未知

Development of a Symptom Scale of Gastroesophageal Reflux Disease (GERD)

Specified Nonprofit Organization Institute for Health Outcomes & Process Evaluation research (iHope International)0 sites440 target enrollmentMarch 2, 2016

Overview

Phase
未知
Intervention
Not specified
Conditions
Gastroesophageal Reflux Disease (GERD)
Sponsor
Specified Nonprofit Organization Institute for Health Outcomes & Process Evaluation research (iHope International)
Enrollment
440
Status
Other
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
March 2, 2016
End Date
TBD
Last Updated
2 years ago
Study Type
Observational
Sex
All

Investigators

Sponsor
Specified Nonprofit Organization Institute for Health Outcomes & Process Evaluation research (iHope International)

Eligibility Criteria

Inclusion Criteria

  • 1\) \[Common to Steps 1 to 3]
  • 1\.Patients who have been diagnosed with GERD (including reflux esophagitis and non\-erosive gastroesophageal reflux disease) during routine medical care and have GERD symptoms
  • 2\.Male or female and is aged 20 years or older at the time of informed consent
  • 2\) \[Step 1] Qualitative study (individual or group interview)
  • 3\.Patients capable of understanding the questions of the research team member or examiner and those capable of verbally explaining their own symptoms.
  • 3\) \[Steps 2 and 3]
  • Patients with untreated gastroesophageal reflux disease and are planning to undergo treatment with a proton pump inhibitor

Exclusion Criteria

  • 1\.Patients strongly suspected of having ischemic heart disease
  • 2\.Patients strongly suspected of having asthma or chronic cough
  • 3\.Patients with obvious cognitive dysfunction that would affect the research

Outcomes

Primary Outcomes

Not specified

Similar Trials